C

ContraFect Corp

34 employees

ContraFect is a biotechnology company researching the use of monoclonal antibodies to treat life-threatening infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2008

Funding rounds raised

Total raised

$19M

from 3 investors over 3 rounds

C

ContraFect Corp raised $19M on July 20, 2020

Investors: CARB-X

C

ContraFect Corp raised $6.9M on March 4, 2019

Investors: CARB-X

C

ContraFect Corp raised $2.3M on January 17, 2019

Investors: CARB-X

FAQ